DNTH Dianthus Therapeutics, Inc. /DE/
Nasdaq · SEC CIK 1690585 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $71.20M 20 sales by 8 insiders
- Filings on record
- 147 since 2021-07-08, latest 2026-09-18 16:36
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Garcia Marino | CEO AND Pres, Dir | — | $27.96M |
| Randhawa Simrat | EVP, Head of R, D | — | $15.00M |
| Savitz Ryan | EVP, CFO, CBO | — | $14.29M |
| CARR EDWARD | CAO | — | $5.59M |
| Veness Adam M | SVP, GC, Sec | — | $4.63M |
| Soteropoulos Paula | Dir | — | $2.25M |
| McGeorge Anne | Dir | — | $844.8K |
| Read Simon | Dir | — | $630.8K |
Transactions 80
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-18 16:36 | 2026-09-17 | DNTH | CARR EDWARD | CAO | M - OptEx | $17.88 | +20.0K | 20.0K | New | +$357.6K |
| DMT | 2026-09-18 16:36 | 2026-09-17 | DNTH | CARR EDWARD | CAO | S - Sale+OE | $101.38 | -20.0K | 0 | -100% | -$2.03M |
| DMT | 2026-09-03 16:30 | 2026-09-01 | DNTH | Randhawa Simrat | EVP, Head of R, D | M - OptEx | $20.63 | +23.1K | 27.1K | +578% | +$477.0K |
| DMT | 2026-09-03 16:30 | 2026-09-01 | DNTH | Randhawa Simrat | EVP, Head of R, D | S - Sale+OE | $106.41 | -23.1K | 4,000 | -85% | -$2.46M |
| DT | 2026-08-19 18:02 | 2026-08-19 | DNTH | Read Simon | Dir | M - OptEx | $18.36 | +2,778 | 2,778 | New | +$51.0K |
| DT | 2026-08-19 18:02 | 2026-08-19 | DNTH | Read Simon | Dir | S - Sale+OE | $117.55 | -2,778 | 0 | -100% | -$326.6K |
| D | 2026-08-14 16:30 | 2026-08-13 | DNTH | Veness Adam M | SVP, GC, Sec | M - OptEx | $18.17 | +15.0K | 15.0K | New | +$272.6K |
| DMT | 2026-08-11 17:15 | 2026-08-10 | DNTH | McGeorge Anne | Dir | M - OptEx | $12.52 | +7,750 | 7,750 | New | +$97.0K |
| DMT | 2026-08-11 17:15 | 2026-08-10 | DNTH | McGeorge Anne | Dir | S - Sale+OE | $109.01 | -7,750 | 0 | -100% | -$844.8K |
| DT | 2026-08-11 17:10 | 2026-08-10 | DNTH | Read Simon | Dir | M - OptEx | $18.36 | +2,777 | 2,777 | New | +$51.0K |
| DMT | 2026-08-11 17:10 | 2026-08-10 | DNTH | Read Simon | Dir | S - Sale+OE | $109.55 | -2,777 | 0 | -100% | -$304.2K |
| DMT | 2026-08-11 17:08 | 2026-08-07+ | DNTH | Veness Adam M | SVP, GC, Sec | M - OptEx | $17.88 | +20.0K | 16.2K | New | +$357.6K |
| DMT | 2026-08-11 17:08 | 2026-08-07+ | DNTH | Veness Adam M | SVP, GC, Sec | S - Sale+OE | $110.44 | -20.0K | 0 | -100% | -$2.21M |
| DMT | 2026-08-07 18:30 | 2026-08-07 | DNTH | Garcia Marino | CEO AND Pres, Dir | M - OptEx | $8.44 | +166.0K | 231.3K | +254% | +$1.40M |
| DMT | 2026-08-07 18:30 | 2026-08-07 | DNTH | Garcia Marino | CEO AND Pres, Dir | S - Sale+OE | $108.11 | -166.0K | 65.3K | -72% | -$17.95M |
| DT | 2026-07-13 17:00 | 2026-07-09 | DNTH | Savitz Ryan | EVP, CFO, CBO | M - OptEx | $21.77 | +31.2K | 31.2K | New | +$680.3K |
| DMT | 2026-07-13 17:00 | 2026-07-09 | DNTH | Savitz Ryan | EVP, CFO, CBO | S - Sale+OE | $101.03 | -31.2K | 0 | -100% | -$3.16M |
| DT | 2026-06-18 16:30 | 2026-06-17 | DNTH | Veness Adam M | SVP, GC, Sec | M - OptEx | $17.88 | +30.0K | 30.0K | New | +$536.4K |
| DMT | 2026-06-18 16:30 | 2026-06-17 | DNTH | Veness Adam M | SVP, GC, Sec | S - Sale+OE | $80.80 | -30.0K | 0 | -100% | -$2.42M |
| DMT | 2026-06-02 19:00 | 2026-06-01 | DNTH | Randhawa Simrat | EVP, Head of R, D | M - OptEx | $18.85 | +26.5K | 30.5K | +663% | +$500.2K |
| DMT | 2026-06-02 19:00 | 2026-06-01 | DNTH | Randhawa Simrat | EVP, Head of R, D | S - Sale+OE | $90.62 | -26.5K | 4,000 | -87% | -$2.40M |
| DT | 2026-05-11 17:00 | 2026-05-08 | DNTH | Soteropoulos Paula | Dir | M - OptEx | $8.44 | +599 | 599 | New | +$5,056 |
| DT | 2026-05-11 17:00 | 2026-05-08 | DNTH | Soteropoulos Paula | Dir | S - Sale+OE | $85.47 | -599 | 0 | -100% | -$51.2K |
| DT | 2026-04-10 16:52 | 2026-04-09 | DNTH | Savitz Ryan | EVP, CFO, CBO | M - OptEx | $17.88 | +8,224 | 8,224 | New | +$147.0K |
| DT | 2026-04-10 16:52 | 2026-04-09 | DNTH | Savitz Ryan | EVP, CFO, CBO | S - Sale+OE | $89.84 | -8,224 | 0 | -100% | -$738.8K |
| DMT | 2026-04-01 17:26 | 2026-03-31 | DNTH | Savitz Ryan | EVP, CFO, CBO | M - OptEx | $11.74 | +114.4K | 114.4K | New | +$1.34M |
| DMT | 2026-04-01 17:26 | 2026-03-31 | DNTH | Savitz Ryan | EVP, CFO, CBO | S - Sale+OE | $83.00 | -114.4K | 0 | -100% | -$9.49M |
| DT | 2026-04-01 17:26 | 2026-03-31 | DNTH | Soteropoulos Paula | Dir | M - OptEx | $8.44 | +599 | 599 | New | +$5,056 |
| DT | 2026-04-01 17:26 | 2026-03-31 | DNTH | Soteropoulos Paula | Dir | S - Sale+OE | $80.11 | -599 | 0 | -100% | -$48.0K |
| DT | 2026-03-26 | 2026-03-24 | DNTH | Soteropoulos Paula | Dir | S - Sale+OE | $78.05 | -27.6K | 0 | -100% | -$2.15M |
| DT | 2026-03-26 | 2026-03-24 | DNTH | Soteropoulos Paula | Dir | M - OptEx | $8.44 | +27.6K | 27.6K | New | +$232.9K |
| DM | 2026-03-17 | 2026-03-16 | DNTH | Garcia Marino | CEO AND Pres, Dir | M - OptEx | $7.66 | +65.3K | 65.3K | New | +$500.0K |
| DMT | 2026-03-13 | 2026-03-12 | DNTH | CARR EDWARD | CAO | M - OptEx | $20.45 | +43.7K | 16.2K | New | +$893.3K |
| DMT | 2026-03-13 | 2026-03-12 | DNTH | CARR EDWARD | CAO | S - Sale+OE | $81.49 | -43.7K | 4,365 | -91% | -$3.56M |
| DMT | 2026-03-13 | 2026-03-12 | DNTH | Garcia Marino | CEO AND Pres, Dir | S - Sale+OE | $81.49 | -122.9K | 0 | -100% | -$10.02M |
| DT | 2026-03-13 | 2026-03-12 | DNTH | Garcia Marino | CEO AND Pres, Dir | M - OptEx | $6.70 | +122.9K | 122.9K | New | +$823.6K |
| DMT | 2026-03-13 | 2026-03-12 | DNTH | Randhawa Simrat | EVP, Head of R, D | M - OptEx | $18.15 | +33.8K | 7,998 | New | +$614.2K |
| DT | 2026-03-13 | 2026-03-12 | DNTH | Randhawa Simrat | EVP, Head of R, D | S - Sale+OE | $81.48 | -33.8K | 0 | -100% | -$2.76M |
| DT | 2025-12-05 | 2025-12-04 | DNTH | Savitz Ryan | CFO, CBO | S - Sale+OE | $45.18 | -20.0K | 0 | -100% | -$903.6K |
| DT | 2025-12-05 | 2025-12-04 | DNTH | Savitz Ryan | CFO, CBO | M - OptEx | $8.44 | +20.0K | 20.0K | New | +$168.8K |
| DMT | 2025-11-14 | 2025-11-13+ | DNTH | Randhawa Simrat | EVP, Head of R, D | M - OptEx | $15.25 | +196.5K | 91.5K | New | +$3.00M |
| DMT | 2025-11-14 | 2025-11-13+ | DNTH | Randhawa Simrat | EVP, Head of R, D | S - Sale+OE | $37.55 | -196.5K | 65.3K | -75% | -$7.38M |
| DT | 2025-09-11 | 2025-09-09 | DNTH | Savitz Ryan | CFO, CBO | S - Sale+OE | $35.00 | -20.0K | 0 | -100% | -$700.0K |
| DT | 2025-09-11 | 2025-09-09 | DNTH | Savitz Ryan | CFO, CBO | M - OptEx | $8.44 | +20.0K | 20.0K | New | +$168.8K |
| I | 2024-10-01 | 2024-09-27 | DNTH | Kiselak Tomas | Dir | J - Other | $0.00 | -62.1K | 0 | -100% | $0 |
| MI | 2024-04-01 | 2024-04-01 | DNTH | Kiselak Tomas | Dir, 10% | J - Other | — | 0 | 0 | New | — |
| DI | 2024-01-24 | 2024-01-22 | DNTH | Fairmount Funds Management LLC | Dir, 10% | A - Grant | $12.00 | +834.3K | 2.76M | +43% | +$10.01M |
| DI | 2024-01-24 | 2024-01-22 | DNTH | Avidity Partners Management (GP) LLC | Dir | A - Grant | $12.00 | +1.50M | 2.72M | +123% | +$18.00M |
| I | 2024-01-24 | 2024-01-22 | DNTH | MOULDER LEON O JR | Dir | A - Grant | $12.00 | +166.7K | 1.44M | +13% | +$2.00M |
| I | 2023-10-03 | 2023-09-29 | DNTH | Harwin Peter Evan | Dir, 10% | P - Purchase | $13.63 | +24.7K | 1.93M | +1% | +$336.3K |
| I | 2023-09-28 | 2023-09-26 | DNTH | Kiselak Tomas | Dir, 10% | P - Purchase | $13.15 | +30.0K | 1.90M | +2% | +$394.5K |
| M | 2023-09-25 | 2023-09-21+ | DNTH | Randhawa Simrat | Chief Medical Off | P - Purchase | $13.20 | +4,000 | 4,000 | New | +$52.8K |
| I | 2023-09-21 | 2023-09-19 | DNTH | Kiselak Tomas | Dir, 10% | P - Purchase | $13.20 | +30.0K | 1.87M | +2% | +$396.0K |
| DMI | 2023-09-13 | 2023-09-12+ | DNTH | Kiselak Tomas | Dir, 10% | P - Purchase | $11.20 | +24.3K | 1.83M | +1% | +$271.7K |
| M | 2023-02-09 | 2023-02-07+ | DNTH | TRV GP IV, LLC | 10% | S - Sale | $0.8259 | -3.70M | 3.06M | -55% | -$3.06M |
| 2022-12-02 | 2022-11-30 | DNTH | Mahoney Stephen F. | See Remarks | A - Grant | $0.94 | +3,000 | 17.3K | +21% | +$2,820 | |
| 2022-12-02 | 2022-11-30 | DNTH | Beetham Thomas W. | See Remarks | A - Grant | $0.94 | +3,000 | 19.9K | +18% | +$2,820 | |
| 2022-12-02 | 2022-11-30 | DNTH | GARDNER JASON | See Remarks, Dir | A - Grant | $0.94 | +3,000 | 292.9K | +1% | +$2,820 | |
| 2022-12-02 | 2022-11-30 | DNTH | Stants Kristen | CHRO | A - Grant | $0.94 | +3,000 | 20.3K | +17% | +$2,820 | |
| 2022-12-02 | 2022-11-30 | DNTH | Deardorf Caren | Chief Commercial Off | A - Grant | $0.94 | +3,000 | 19.8K | +18% | +$2,820 | |
| 2022-06-06 | 2022-05-31 | DNTH | Deardorf Caren | Chief Commercial Off | A - Grant | $0.99 | +3,000 | 16.8K | +22% | +$2,970 | |
| 2022-06-06 | 2022-05-31 | DNTH | Beetham Thomas W. | See Remarks | A - Grant | $0.99 | +3,000 | 16.9K | +22% | +$2,970 | |
| 2022-06-06 | 2022-05-31 | DNTH | Stants Kristen | CHRO | A - Grant | $0.99 | +3,000 | 17.3K | +21% | +$2,970 | |
| 2022-06-06 | 2022-05-31 | DNTH | GARDNER JASON | See Remarks, Dir | A - Grant | $0.99 | +3,000 | 289.9K | +1% | +$2,970 | |
| 2021-09-23 | 2021-08-26 | DNTH | Borisy Alexis | Dir | J - Other | $0.00 | +4,100 | 4,100 | New | $0 | |
| 2021-09-20 | 2021-09-16 | DNTH | Beetham Thomas W. | See Remarks | S - Sale | $6.73 | -6,103 | 13.9K | -31% | -$41.1K | |
| 2021-09-20 | 2021-09-16 | DNTH | GARDNER JASON | See Remarks | S - Sale | $6.73 | -14.3K | 286.9K | -5% | -$96.5K | |
| 2021-09-20 | 2021-09-16 | DNTH | Nichols David Wayne | Chief Technical Off | S - Sale | $6.73 | -5,694 | 14.3K | -28% | -$38.3K | |
| 2021-09-20 | 2021-09-16 | DNTH | Deardorf Caren | Chief Commercial Off | S - Sale | $6.73 | -6,238 | 13.8K | -31% | -$42.0K | |
| 2021-09-20 | 2021-09-16 | DNTH | Stants Kristen | CHRO | S - Sale | $6.73 | -5,736 | 14.3K | -29% | -$38.6K | |
| 2021-09-20 | 2021-09-16 | DNTH | Mahoney Stephen F. | See Remarks | S - Sale | $6.73 | -5,736 | 14.3K | -29% | -$38.6K | |
| 2021-09-20 | 2021-09-16 | DNTH | Olson Lisa | See Remarks | S - Sale | $6.73 | -5,736 | 14.3K | -29% | -$38.6K | |
| 2021-09-16 | 2021-09-14 | DNTH | Olson Lisa | See Remarks | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 | |
| 2021-09-16 | 2021-09-14 | DNTH | Mahoney Stephen F. | See Remarks | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 | |
| 2021-09-16 | 2021-09-14 | DNTH | Deardorf Caren | Chief Commercial Off | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 | |
| 2021-09-16 | 2021-09-14 | DNTH | Nichols David Wayne | Chief Technical Off | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 | |
| 2021-09-16 | 2021-09-14 | DNTH | GARDNER JASON | See Remarks, Dir | A - Grant | $0.00 | +50.0K | 301.2K | +20% | $0 | |
| 2021-09-16 | 2021-09-14 | DNTH | Stants Kristen | CHRO | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 | |
| 2021-09-16 | 2021-09-14 | DNTH | Beetham Thomas W. | See Remarks | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 | |
| 2021-08-26 | 2021-08-25 | DNTH | Third Rock Ventures GP IV, L.P. | 10% | J - Other | — | -1.25M | 6.76M | -16% | — |
Purchase Sale Sale after option exercise All abbreviations